PABPN1 and cancer: Further investigation into PABPN1 expression across different immune subtypes and molecular subtypes of human cancers, using the TISIDB website, unveiled significant variations in PABPN1 expression in many cancer types such as BRCA, HNSC, LGG, STAD, suggesting its potential role as a diagnostic pan-cancer biomarker and involvement in immune regulation.